MarketPeel
Insider Trading Intelligence
GR

Gilead Raday

RDHL
CHIEF OPERATING OFFICER · REDHILL BIOPHARMA LTD. · CIK 0002113137
FILING MIX · LIFETIME50%/50%
BUYS
2
SELLS
2
TOTAL VALUE
$3.0K
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
104,130,000
AVG SELL PX
$0.00
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Gilead Raday, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-1.93%+4.12%-6.05%-6.05%
14d1+100.00%-4.58%+7.56%-12.14%-12.14%
30d1+0.00%+23.04%+11.37%+11.67%+11.67%
60d1+14.91%
90d1+100.00%-2.05%+13.03%-15.08%-15.08%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RDHL · 104,130,000 shares · as of Jul 10, 2026
065,265,000130,530,000195,795,000261,060,000SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 2 buys / 2 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RDHL
REDHILL BIOPHARMA LTD.
PURCHASE
Chief Operating Officer
28,150,000104,130,000Jul 10, 2026Jul 13, 2026View →
RDHL
REDHILL BIOPHARMA LTD.
SALE
Chief Operating Officer
14,130,000$0.00$1.4K218,780,000Jul 10, 2026Jul 13, 2026View →
RDHL
REDHILL BIOPHARMA LTD.
SALE
Chief Operating Officer
15,740,000$0.00$1.6K261,060,000Apr 6, 2026Apr 22, 2026View →
RDHL
REDHILL BIOPHARMA LTD.
PURCHASE
Chief Operating Officer
30,780,00076,150,000Apr 6, 2026Apr 22, 2026View →
Other insiders · RDHL
Loading peer insiders…
About this filer
CIK 0002113137
ROLE
Chief Operating Officer
PRIMARY
RDHL
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002113137DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback